Lifecore Biomedical, Inc. LFCR Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s shares (diluted)?
- Lifecore Biomedical, Inc. (LFCR) reported shares (diluted) of 37.5M in Q1 2026.
- How has Lifecore Biomedical, Inc.'s shares (diluted) changed year-over-year?
- Lifecore Biomedical, Inc.'s shares (diluted) increased by 7.6% year-over-year, from 34.8M to 37.5M.
- What is the long-term trend for Lifecore Biomedical, Inc.'s shares (diluted)?
- Over 3 years (2022 to 2025), Lifecore Biomedical, Inc.'s shares (diluted) has grown at a 5.2% compound annual growth rate (CAGR), from 117.8M to 137.1M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.